1. Home
  2. VERU vs NSYS Comparison

VERU vs NSYS Comparison

Compare VERU & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

N/A

Current Price

$2.63

Market Cap

48.2M

Sector

Health Care

ML Signal

N/A

NSYS

Nortech Systems Incorporated

N/A

Current Price

$12.21

Market Cap

40.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
VERU
NSYS
Founded
1971
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
48.2M
40.1M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
VERU
NSYS
Price
$2.63
$12.21
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
278.7K
14.2K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.85
EPS
N/A
0.09
Revenue
$16,296,958.00
$14,371,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$134.56
Revenue Growth
N/A
7.01
52 Week Low
$2.05
$6.50
52 Week High
$7.33
$18.01

Technical Indicators

Market Signals
Indicator
VERU
NSYS
Relative Strength Index (RSI) 54.95 39.55
Support Level $2.12 $11.94
Resistance Level $2.67 $15.35
Average True Range (ATR) 0.14 1.07
MACD 0.06 -0.18
Stochastic Oscillator 65.75 18.16

Price Performance

Historical Comparison
VERU
NSYS

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

Share on Social Networks: